Med Tech Company Opposes Review Of Overturned $340M Antitrust Award
(March 3, 2017, 7:28 AM EST) -- WASHINGTON, D.C. — In a dispute over entitlement to a treble damages award for attempted monopolization under Section 2 of the Sherman Act, a medical technology company argues in a Feb....
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login